Due to an error in the production process, the Therapy Update in the August issue of the journal (Gut 2002;51:182–3) was missing references 14 to 24. The references are printed below, and Gut apologises for the omission.
References
- 14.
Campieri M, Ferguson A, Doe W, et al. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group. Gut1997;41:209–14.
- 15.
Thomsen OO, Cortot A, Jewell D, et al. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med1998;339:370–4.
- 16.
Irvine EJ, Greenberg GR, Feagan BG, et al. Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Inflamm Bowel Dis2000;6:181–7.
- 17.
Florin TH, Graffner H, Nilsson LG, et al. Treatment of joint pain in Crohn's patients with budesonide controlled ileal release. Clin Exp Pharmacol Physiol2000;27:295–8.
- 18.
Cortot A, Colombel JF, Rutgeerts P, et al. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease. Gut2001;48:186–90.
- 19.
Lofberg R, Rutgeerts P, Malchow H, et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut1996;39:82–6.
- 20.
Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology1996;110:45–51.
- 21.
Gross V, Andus T, Ecker KW, et al. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group. Gut1998;42:493–6.
- 22.
Ewe K, Bottger T, Buhr HJ, et al. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol1999;11:277–82.
- 23.
Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology1999;116:294–300.
- 24.
Papi C, Luchetti R, Gili L, et al. Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther2000;14:1419–28.